OKYO Pharma Announced That It Has Been Notified That Panetta Partners Limited, An Entity In Which Gabriele Cerrone, The Executive Chairman Has A Beneficial Interest, Purchased 35,000 Of The Company's Ordinary Shares On Nasdaq At A Price Of $1.00 Per Share
Portfolio Pulse from Benzinga Newsdesk
OKYO Pharma's Executive Chairman, Gabriele Cerrone, through Panetta Partners Limited, purchased 35,000 shares of OKYO Pharma on Nasdaq at $1.00 per share.
August 21, 2024 | 11:01 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Gabriele Cerrone, Executive Chairman of OKYO Pharma, has increased his stake by purchasing 35,000 shares at $1.00 each, indicating confidence in the company's prospects.
The purchase of shares by an insider, especially at the executive level, often signals confidence in the company's future performance. This can lead to a positive short-term impact on the stock price as investors may interpret this as a bullish sign.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100